**PURPOSE:** Recent studies have demonstrated the functional heterogeneity of fibroblasts, particularly in terms of their activities during wound healing. Both location within the dermis and embryonic lineages^1^ provide a means by which we may now identify the sub-populations of fibroblasts chiefly responsible for connective tissue deposition during scar formation in the dorsal dermis.^1,2^ However, whether these findings translate to the ventral dermis have yet to be elucidated.

**METHODS:** *Prrx1*^*Cre*^*/Rosa26*^*mTmG*^ mice, were used to trace two fibroblast lineages restricted to the ventral dermis. Fibroblasts of different embryonic lineages---based on *Prrx1* expression---were isolated from ventral fetal and adult dermis at a series of time points, including the late-gestational transition from scarless to scar-forming wound healing. ATAC-seq (Assay for Transposase-Accessible Chromatin with high throughput sequencing) was also performed in isolated pre- and post-gestational fibroblasts.

**RESULTS:** Histological analysis revealed that the *Prrx1*-positive lineage contributed to the majority of connective tissue during scar formation. Flow cytometry demonstrated a shift in fibroblast sub-populations over the course of gestation. Differential patterns of chromatin accessibility shown by ATAC-seq further demonstrated the heterogeneic nature of fibroblasts within the ventral dermis at an epigenetic level.

**CONCLUSIONS:** As in the dorsal dermis, fibroblasts of the ventral dermis demonstrate functional heterogeneity. Further studies may allow targeting of specific sub-populations to improve wound healing.
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